Norion Biosimilars
SHORT CODE
NB28
MODEL
Continuous publication
STATUS
In preparation - editorial board being constituted
Aims and scope
Original research and reviews in biosimilars. Norion Biosimilars publishes continuously: accepted articles appear the day of acceptance, each with its own article number in the year's rolling volume. Every submission is peer reviewed, and every decision rests with the journal's editors.